APA (7th ed.) Citation

Bozoglan, M. Y., Kuloglu, T., Gozel, N., Kılınc, F., Cakmak, E., Akkoç, R. F., & Hark, B. D. Metformin Increases Serum Isthmin-1 Levels and Lowers Low-Density Lipoprotein: Potential Implications for Lipid Metabolism in T2DM. MDPI AG.

Chicago Style (17th ed.) Citation

Bozoglan, Merve Yilmaz, Tuncay Kuloglu, Nevzat Gozel, Faruk Kılınc, Erkan Cakmak, Ramazan Fazıl Akkoç, and Betül Dağoğlu Hark. Metformin Increases Serum Isthmin-1 Levels and Lowers Low-Density Lipoprotein: Potential Implications for Lipid Metabolism in T2DM. MDPI AG.

MLA (9th ed.) Citation

Bozoglan, Merve Yilmaz, et al. Metformin Increases Serum Isthmin-1 Levels and Lowers Low-Density Lipoprotein: Potential Implications for Lipid Metabolism in T2DM. MDPI AG.